Scottsdale
Freeway partner cityData as of Oct 1, 2026Venture funding by year
Show as a table
| Year | Venture funding | Rounds |
|---|---|---|
| 2019 | $780.1M | 52 |
| 2020 | $152.7M | 41 |
| 2021 | $1.2B | 68 |
| 2022 | $502.4M | 53 |
| 2023 | $603.4M | 45 |
| 2024 | $84.1M | 24 |
| 2025 | $60.8M | 7 |
| 2026* | $58.6M | 12 |
Industries
- Health275
- Fintech171
- Enterprise software157
- Marketing153
- Real estate104
- Food67
- Education65
- Media60
- Energy57
- Wellness & beauty56
And 20 more industries.
Companies in Scottsdale
97–120 of 1,830 companies
- Amuletbb
Home & living
Early stage · 2–10 employees
- Amurta
Enterprise software
Early stage · 1 employees
- Anchored RE
Fintech, Real estate
Anchored RE is a private lending and capital advisory firm operating nationwide from its headquarters in Scottsdale, Arizona. The firm provides financing solutions tailored for real estate investors, developers, and operators who require speed and flexibility. Bjugan began his career at a young age and formally entered the land development industry at 24, inspired by his grandfather, who was a prominent land developer and homebuilder. His background includes studying finance and business before starting his first development company, Allied Development, in the early 2000s, which specializes in the acquisition and entitlement of raw land for residential communities. This experience as a principal developer informs Anchored RE's underwriting approach, which focuses on a deep understanding of deal mechanics rather than just paperwork.Anchored RE's services cater to a broad spectrum of real estate investment needs. The firm offers a range of loan products, including hard money loans, short-term bridge financing, DSCR rental loans for investors, and capital for ground-up construction. It also facilitates commercial bridge loans and portfolio or blanket refinances. The company's business model serves borrowers seeking reliable capital and capital partners looking for well-vetted, clean loan packages structured to close efficiently.
Early stage · 1 employees
Early stage
- Anekdotz
Music, Dating
Early stage · 2–10 employees
Angel MedFlight is a leading provider of air ambulance services in the United States, specializing in the transport of critically ill patients. The company operates a fleet of medically configured jet aircraft equipped with intensive care unit (ICU) capabilities. Angel MedFlight's core service involves the safe and rapid transfer of patients requiring advanced medical care, facilitated by a team of Certified Flight Nurses and Certified Flight Paramedics who hold advanced certifications exceeding industry standards.Founded in 2007, Angel MedFlight serves a diverse range of clients, including individual patients, hospitals, and case managers who need reliable and efficient medical transportation solutions. The company operates in the healthcare and emergency medical services market, focusing on providing high-quality care during air transport.Angel MedFlight's business model revolves around offering premium air ambulance services, generating revenue through service fees charged for each medical transport. The company is recognized for its commitment to patient care and has received accolades such as the Pro Patria Award for Employer Support of the Guard and Reserve.
Breakout · 51–200 employees
- Annexus
Fintech
Annexus specializes in the innovation, development, and distribution of retirement income and accumulation products. The company collaborates with some of the largest financial and insurance firms to create next-generation retirement solutions. Annexus operates in the financial services market, focusing on retirement planning and annuities. Its business model revolves around partnerships with major industry players like AIG, Athene, and Transamerica to deliver tailored retirement products. Annexus generates revenue through these partnerships by providing unique, market-leading retirement solutions that cater to various client needs, including income for life, inflation protection, and risk-free accumulation. The company serves a diverse clientele, primarily financial advisors and insurance companies, who in turn offer these products to end consumers seeking secure and innovative retirement options.
Early stage · 51–200 employees
Early stage · 2–10 employees
- Antler Farms
Food
Early stage · 1 employees
- Anuncia Inc
Health
Anuncia Inc. specializes in developing medical devices aimed at treating cerebrospinal fluid (CSF) disorders, such as hydrocephalus, which require draining or shunting of CSF. The company's flagship product, the ReFlow Ventricular System, is FDA cleared and CE Marked, designed to facilitate a safe, noninvasive retrograde fluid flush when ventriculoperitoneal shunt flow is restricted or blocked. This system is a prescription device sold by or on the order of a physician and is intended for use by qualified clinicians. Anuncia Inc. is also developing the ReFlow System Mini, which has received FDA Breakthrough Device Designation but is not yet available for sale. The company operates in the MedTech market, targeting healthcare providers and institutions that treat patients with CSF disorders. Anuncia Inc. generates revenue through the sale of its medical devices, leveraging its innovative technology to address critical needs in the treatment of CSF disorders. The company has been recognized with awards such as the Fast Company 2021 World Changing Ideas Award, highlighting its impact and potential in the medical technology field.
Early stage · 11–50 employees · $20K raised
- Anuncia Medical, Inc.
Health
Anuncia Medical, Inc. is a commercial-stage neuro-therapeutic device company focused on managing cerebrospinal fluid (CSF) disorders, primarily hydrocephalus. The current President and CEO is Elsa Chi Abruzzo, a medical device industry veteran who joined as a founding member. The company's core business revolves around its flagship ReFlow® technology platform, designed to address the high failure rate of CSF shunts, which are the standard treatment for hydrocephalus. Shunt failure, often caused by blockages (occlusions), typically requires costly and high-risk revision brain surgeries. Anuncia's solution is an implanted device that allows for noninvasive flushing of the shunt's ventricular catheter to clear obstructions and maintain, restore, or increase CSF flow. This procedure can be performed by trained healthcare professionals in a clinic or by caregivers and patients at home, under a physician's direction. Anuncia's main product is the ReFlow® System Mini Flusher, a second-generation device that is smaller and designed for a broader patient population, from infants to adults. The device is implanted under the scalp in-line with the neurosurgeon's preferred shunt system. A simple press on the device's dome sends a controlled, small pulse of the patient's own CSF to clear blockages in the catheter's inlet holes. The ReFlow® System Mini received FDA 510(k) clearance in September 2022, enabling its commercialization in the U.S. The technology has also earned multiple FDA Breakthrough Device Designations for its potential to noninvasively clear catheter occlusions and for its application in external ventricular drains (EVDs) used in neurocritical care. The company operates in the neurocritical care and medical device market, serving clients such as neurosurgeons, hospitals, and patients with hydrocephalus. Anuncia has raised $17.7 million in funding and is actively expanding its commercial footprint across the U.S. It also engages in global health initiatives, partnering with organizations like NeuroKids.org to bring its technology to underserved populations in Africa.
Early stage · 11–50 employees · $100K raised
- AP Professionals
Jobs & recruitment
Breakout · 51–200 employees
Early stage · 2–10 employees
Early stage
- Applied Biologics
Health
Early stage · 11–50 employees
- Appointment-Plus
Security
Breakout · 51–200 employees
- Apricus Health
Health
Apricus Health is a healthcare startup that focuses on providing proactive and integrated healthcare solutions. The company operates primarily in Arizona and has expanded its network to include over 500 primary care physicians and specialists. Apricus Health aims to improve health outcomes by shifting from reactive, episodic care to a continuous care relationship. This means they focus on long-term health strategies, including preventive care, chronic care management, and optimizing specialty care referrals.The business serves a wide range of clients, including individual patients seeking primary and specialty care, healthcare providers looking for a network to join, and health plans aiming to offer comprehensive care options to their members. Apricus Health operates in the healthcare market, specifically targeting population health management and integrated care services.The business model of Apricus Health revolves around a combination of direct patient care and partnerships with healthcare providers and health plans. They offer various services such as primary care, telehealth, lab testing, and house calls. By providing these services, Apricus Health generates revenue through patient visits, telehealth consultations, and partnerships with health plans that pay for the comprehensive care provided to their members.Recently, Apricus Health has joined the Optum family, a move that aligns with its mission to make healthcare simpler and more affordable. This partnership is expected to enhance their ability to provide high-quality care while keeping costs manageable for patients.In summary, Apricus Health is a physician-led healthcare network that focuses on proactive, continuous care to improve health outcomes. They serve individual patients, healthcare providers, and health plans, operating primarily in Arizona with a growing network of over 500 healthcare professionals.
Breakout · 11–50 employees · $20.0M raised
Early stage · 1 employees
- Aption
Fintech
Aption offers a financial platform designed to address the high-risk, illiquid nature of equity held by startup founders, executives, and early employees. The company, founded in 2022 and based in Scottsdale, Arizona, enables these stakeholders to diversify their concentrated equity positions. Aption's core service is "Equity Pooling," which allows individuals to contribute a portion of their startup equity into a larger, diversified portfolio alongside peers from other promising, high-growth companies. This model is designed to mitigate the inherent risk of having substantial personal wealth tied to a single speculative venture, transforming it into a more responsible portfolio with a higher probability of a financial return. The business operates on a model where it earns a management fee only upon a liquidity event, meaning there are no upfront costs for the user. Aption utilizes a proprietary, AI-driven engine that analyzes public, purchased, and internal data to create statistically balanced pools of similarly-promising companies. This technology facilitates the matching and programmatic placement of new assets into the pools, ensuring the diversification is valuable regardless of the individual's original company position. The legal and tax structuring is designed to be efficient, allowing for the hedging and management of venture positions without requiring board approval or updates to the company's cap table. When a company within a pool has a liquidity event, such as an acquisition, the returns are shared pro-rata among the pool's members. Aption was co-founded by Alon Zieve, who serves as the CEO. The company addresses a significant pain point in the venture ecosystem, where exit timelines are lengthening and markets are volatile, making concentrated, illiquid positions increasingly precarious. In September 2024, Aption announced it had secured a $2.4 million funding round led by Motivate VC and Recursive Ventures, with participation from Carthona Capital. This capital is intended to further develop its AI technology, enhance the platform, and expand sales efforts, particularly in the U.S. market.
Early stage · 2–10 employees · $2.4M raised
- Aquavitas
Health
Early stage · 1 employees
- Arcadia Capital Group
Real estate
Early stage · 2–10 employees
- AREIA Synthetics
Real estate
AREIA Synthetics creates intelligent, hyper-realistic synthetic humans to serve as digital brand ambassadors, primarily for the real estate sector. Their main product, Areia™, which stands for Autonomous Real Estate Intelligence Assistant, is an AI-powered avatar designed to interact with customers on websites, CRMs, and other digital platforms. It assists with consumer engagement by answering questions, guiding property searches, and nurturing leads to make the home buying and selling process more personal and seamless. The company combines Hollywood-level visual effects (VFX) and computer-generated imagery (CGI) with extensive data and business intelligence from the property technology (proptech) space. Areia operates on the proprietary AREIA Experience Engine™, a patent-pending system that orchestrates multiple leading AI models—such as those from OpenAI, Google, and Anthropic—in real-time to provide context-aware and brand-safe responses. This multi-model approach allows the platform to select the best AI for a specific task, ensuring optimal outcomes. The technology is fluent in over 70 languages and is designed for global real estate markets, with considerations for Fair Housing, GDPR/CCPA, and ADA compliance. AREIA Synthetics partners with technology companies, brokerages, franchises, and SaaS platforms to distribute its technology. One of its key strategic partners is RELIANCEai, a provider of enterprise real estate technology, which holds an investment interest in AREIA Synthetics and is deploying the Areia assistant across its ecosystem. The company was in a private testing phase with a phased rollout planned for early 2026.
Early stage
- Arie Custom Lighting
Home & living
Early stage
- Aritronix
Home & living
Early stage
Recent venture rounds
| Company | Round | Amount | Date | Investors |
|---|---|---|---|---|
| Monetary Metals | Early VC | $10.5M | Sep 2026 | Not disclosed |
| Sparkle Grooming Co. | Early VC | $6.0M | Sep 2026 | Mars Petcare, Digitalis Ventures |
| Anuncia Medical, Inc. | Early VC | $100K | Aug 2026 | Accelerating Angels |
| CND Life Sciences | Early VC | Undisclosed | Aug 2026 | Curve Partners |
| One Raven | Seed | $5.0M | Jul 2026 | Fifth Wall Ventures |
| Health Endeavors | Growth Equity VC | Undisclosed | Jul 2026 | Decathlon Capital Partners |
| Atlys | Angel | Undisclosed | Jul 2026 | Not disclosed |
| equipifi | Series B | $34.0M | May 2026 | SixThirty Ventures, New Stack Ventures, Rise of the Rest +7 more |
| v4c.ai | Series A | Undisclosed | May 2026 | Tquila, Databricks Ventures |
| Veterinary Sales & Marketing | Growth Equity VC | Undisclosed | Apr 2026 | Chinook Investment Partners |